ATE243479T1 - Medizinische vorrichtung mit nukleinsäurehaltiger synthetischer oberfläche zur in-vivo induktion seiner endothelialisierung - Google Patents

Medizinische vorrichtung mit nukleinsäurehaltiger synthetischer oberfläche zur in-vivo induktion seiner endothelialisierung

Info

Publication number
ATE243479T1
ATE243479T1 AT00986137T AT00986137T ATE243479T1 AT E243479 T1 ATE243479 T1 AT E243479T1 AT 00986137 T AT00986137 T AT 00986137T AT 00986137 T AT00986137 T AT 00986137T AT E243479 T1 ATE243479 T1 AT E243479T1
Authority
AT
Austria
Prior art keywords
nucleic acid
synthetic surface
present
medical device
endothelialization
Prior art date
Application number
AT00986137T
Other languages
German (de)
English (en)
Inventor
Mika Lahtinen
Original Assignee
Xenerate Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9904454A external-priority patent/SE9904454D0/xx
Priority claimed from SE9904747A external-priority patent/SE9904747D0/xx
Application filed by Xenerate Ab filed Critical Xenerate Ab
Application granted granted Critical
Publication of ATE243479T1 publication Critical patent/ATE243479T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/258—Genetic materials, DNA, RNA, genes, vectors, e.g. plasmids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgical Instruments (AREA)
  • External Artificial Organs (AREA)
  • Eye Examination Apparatus (AREA)
AT00986137T 1999-12-07 2000-12-07 Medizinische vorrichtung mit nukleinsäurehaltiger synthetischer oberfläche zur in-vivo induktion seiner endothelialisierung ATE243479T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9904454A SE9904454D0 (sv) 1999-12-07 1999-12-07 Medical implant
SE9904747A SE9904747D0 (sv) 1999-12-07 1999-12-23 Medical Implant
SE0000285A SE0000285D0 (sv) 1999-12-07 2000-01-31 Medical implant
PCT/SE2000/002460 WO2001041674A1 (en) 1999-12-07 2000-12-07 Medical device

Publications (1)

Publication Number Publication Date
ATE243479T1 true ATE243479T1 (de) 2003-07-15

Family

ID=27354498

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00986137T ATE243479T1 (de) 1999-12-07 2000-12-07 Medizinische vorrichtung mit nukleinsäurehaltiger synthetischer oberfläche zur in-vivo induktion seiner endothelialisierung

Country Status (12)

Country Link
US (1) US20030059463A1 (enExample)
EP (1) EP1235536B1 (enExample)
JP (1) JP2003516180A (enExample)
CN (1) CN1239133C (enExample)
AT (1) ATE243479T1 (enExample)
AU (1) AU782237B2 (enExample)
CA (1) CA2392284C (enExample)
DE (1) DE60003580T2 (enExample)
DK (1) DK1235536T3 (enExample)
ES (1) ES2206342T3 (enExample)
SE (1) SE0000285D0 (enExample)
WO (1) WO2001041674A1 (enExample)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030008396A1 (en) * 1999-03-17 2003-01-09 Ku David N. Poly(vinyl alcohol) hydrogel
US6596699B2 (en) 1998-09-22 2003-07-22 Biosurface Engineering Technologies, Inc. Nucleic acid coating compositions and methods
US6368658B1 (en) * 1999-04-19 2002-04-09 Scimed Life Systems, Inc. Coating medical devices using air suspension
US7592017B2 (en) * 2000-03-10 2009-09-22 Mast Biosurgery Ag Resorbable thin membranes
US8632583B2 (en) * 2011-05-09 2014-01-21 Palmaz Scientific, Inc. Implantable medical device having enhanced endothelial migration features and methods of making the same
AUPR148400A0 (en) 2000-11-14 2000-12-07 Cochlear Limited Apparatus for delivery of pharmaceuticals to the cochlea
US9089450B2 (en) 2000-11-14 2015-07-28 Cochlear Limited Implantatable component having an accessible lumen and a drug release capsule for introduction into same
ES2305138T3 (es) * 2000-11-27 2008-11-01 Dnavec Research Inc. Vector de paramixovirus que codifica factor 2 de crecimiento de fibroblastos (fgf2) y uso del mismo.
AUPR879201A0 (en) 2001-11-09 2001-12-06 Cochlear Limited Subthreshold stimulation of a cochlea
US20030114923A1 (en) * 2001-11-14 2003-06-19 Swanick Thomas M. Graft and method of making
DK1545389T3 (da) * 2002-07-31 2020-07-20 Mast Biosurgery Ag Indretning til forebyggelse af adhæsioner mellem et implantat og omgivende væv
US8048444B2 (en) * 2002-07-31 2011-11-01 Mast Biosurgery Ag Apparatus and method for preventing adhesions between an implant and surrounding tissues
US7704520B1 (en) 2002-09-10 2010-04-27 Mast Biosurgery Ag Methods of promoting enhanced healing of tissues after cardiac surgery
AT507045B1 (de) * 2002-11-29 2010-04-15 Cochlear Ltd Implantierbare, gewebe-stimulierende vorrichtung
US7627373B2 (en) * 2002-11-30 2009-12-01 Cardiac Pacemakers, Inc. Method and apparatus for cell and electrical therapy of living tissue
US7044965B1 (en) * 2002-12-13 2006-05-16 Spielberg Theodore E Therapeutic cellular stent
US7371256B2 (en) * 2002-12-16 2008-05-13 Poly-Med, Inc Composite vascular constructs with selectively controlled properties
US20060083767A1 (en) * 2003-02-27 2006-04-20 Kai Deusch Surgical prosthesis having biodegradable and nonbiodegradable regions
CA2517250A1 (en) * 2003-02-28 2004-09-10 Schaerer Mayfield Technologies Gmbh Device for localizing, influencing and guiding tracking bodies, and method for operating a marking device
US20040230298A1 (en) * 2003-04-25 2004-11-18 Medtronic Vascular, Inc. Drug-polymer coated stent with polysulfone and styrenic block copolymer
CA2526033A1 (en) * 2003-05-23 2005-03-03 Angiotech International Ag Anastomotic connector devices
DE10328816A1 (de) * 2003-06-21 2005-01-05 Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin Implantierbare Stimulationselektrode mit einer Beschichtung zur Erhöhung der Gewebsverträglichkeit
US20100266663A1 (en) * 2003-09-10 2010-10-21 Calhoun Christopher J Tissue-treating implantable compositions
US8435285B2 (en) * 2003-11-25 2013-05-07 Boston Scientific Scimed, Inc. Composite stent with inner and outer stent elements and method of using the same
US8002830B2 (en) 2004-02-06 2011-08-23 Georgia Tech Research Corporation Surface directed cellular attachment
EP1729678A4 (en) * 2004-02-06 2011-08-10 Georgia Tech Res Inst BEARING BIOCOMPATIBLE DEVICE
US7840263B2 (en) * 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
US8293890B2 (en) 2004-04-30 2012-10-23 Advanced Cardiovascular Systems, Inc. Hyaluronic acid based copolymers
US7764995B2 (en) 2004-06-07 2010-07-27 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
US20050278025A1 (en) * 2004-06-10 2005-12-15 Salumedica Llc Meniscus prosthesis
US7556800B2 (en) * 2004-07-09 2009-07-07 Viscofan, S.A Universal fishing bait based on filaments or strips of fibrous collagen
US7534422B2 (en) * 2004-07-09 2009-05-19 Viscofan, S.A. Universal fishing bait based on fibrous collagen and the procedure for its preparation
US7729761B2 (en) * 2004-07-14 2010-06-01 Cardiac Pacemakers, Inc. Method and apparatus for controlled gene or protein delivery
ATE448752T1 (de) * 2004-07-28 2009-12-15 Cordis Corp Bifurkationsprothese zur reparatur eines bauchaortenaneurysmas
US20080091277A1 (en) * 2004-08-13 2008-04-17 Kai Deusch Surgical prosthesis having biodegradable and nonbiodegradable regions
EP1776065B1 (en) * 2004-08-13 2012-02-15 Mast Biosurgery AG Surgical prosthesis having biodegradable and nonbiodegradable regions
US7919112B2 (en) * 2004-08-26 2011-04-05 Pathak Holdings, Llc Implantable tissue compositions and method
US8060219B2 (en) * 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
US7981065B2 (en) 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
US20070010734A1 (en) * 2005-05-19 2007-01-11 Biophan Technologies, Inc. Electromagnetic resonant circuit sleeve for implantable medical device
US20080119878A1 (en) * 2005-08-12 2008-05-22 Kai Deusch Surgical prosthesis having biodegradable and nonbiodegradable regions
US7774057B2 (en) 2005-09-06 2010-08-10 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression for cardiac protection
US20070134204A1 (en) * 2005-12-09 2007-06-14 Henrich Cheng Method for treating nerve injury and vector construct for the same
US9629626B2 (en) * 2006-02-02 2017-04-25 Covidien Lp Mechanically tuned buttress material to assist with proper formation of surgical element in diseased tissue
US20070190028A1 (en) * 2006-02-13 2007-08-16 Jihong Qu Method and apparatus for heat or electromagnetic control of gene expression
DE102006053260A1 (de) * 2006-07-20 2008-01-24 Clinical House Europe Gmbh Implantat zur Verankerung von Zahnersatz
US20080171972A1 (en) * 2006-10-06 2008-07-17 Stopek Joshua B Medical device package
US8133215B2 (en) 2007-08-13 2012-03-13 Cochlear Limited Independently-manufactured drug delivery module and corresponding receptacle in an implantable medical device
CN101474456B (zh) * 2009-02-09 2012-02-22 乐普（北京）医疗器械股份有限公司 一种携载基因的医疗器械的制备方法
CN101502696B (zh) * 2009-02-17 2012-07-11 乐普（北京）医疗器械股份有限公司 一种携载基因和/或药物的医疗器械及其制备方法
US8617097B2 (en) 2010-05-24 2013-12-31 Cochlear Limited Drug-delivery accessory for an implantable medical device
US8597948B2 (en) 2011-03-10 2013-12-03 First Principles, Inc. Cloned biological material medical device and method thereof
CA2837303C (en) 2011-05-26 2019-08-20 Cartiva, Inc. Tapered joint implant and related tools
US10550187B2 (en) * 2014-10-24 2020-02-04 Incept, Llc Extra luminal scaffold
EP3636226A1 (en) 2015-03-31 2020-04-15 Cartiva, Inc. Carpometacarpal (cmc) implants
CA2981061A1 (en) 2015-03-31 2016-10-06 Cartiva, Inc. Hydrogel implants with porous materials and methods
EP3282961A4 (en) 2015-04-14 2018-12-05 Cartiva, Inc. Tooling for creating tapered opening in tissue and related methods
WO2018226991A1 (en) 2017-06-07 2018-12-13 Shifamed Holdings, Llc Intravascular fluid movement devices, systems, and methods of use
JP7319266B2 (ja) 2017-11-13 2023-08-01 シファメド・ホールディングス・エルエルシー 血管内流体移動デバイス、システム、および使用方法
EP4628147A3 (en) 2018-02-01 2025-11-12 Shifamed Holdings, LLC Intravascular blood pumps
US12161857B2 (en) 2018-07-31 2024-12-10 Shifamed Holdings, Llc Intravascular blood pumps and methods of use
CN108938143A (zh) * 2018-08-15 2018-12-07 湖南工业大学 一种三层结构小口径仿生血管及其制备方法
JP7470108B2 (ja) 2018-10-05 2024-04-17 シファメド・ホールディングス・エルエルシー 血管内血液ポンプおよび使用の方法
WO2021011473A1 (en) 2019-07-12 2021-01-21 Shifamed Holdings, Llc Intravascular blood pumps and methods of manufacture and use
US11654275B2 (en) 2019-07-22 2023-05-23 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
WO2021026473A1 (en) 2019-08-07 2021-02-11 Calomeni Michael Catheter blood pumps and collapsible pump housings
DE102019121562B4 (de) * 2019-08-09 2024-01-11 Acandis Gmbh Medizinische Vorrichtung zur Behandlung von Aneurysmen
EP4034221B1 (en) 2019-09-25 2024-11-13 Shifamed Holdings, LLC Catheter blood pumps and collapsible pump housings
EP4034192B1 (en) 2019-09-25 2025-12-24 Supira Medical, Inc. Intravascular blood pump systems and methods of use and control thereof
EP4034184A4 (en) 2019-09-25 2023-10-18 Shifamed Holdings, LLC CATHETER BLOOD PUMP AND COLLAPSIBLE BLOOD LINES
WO2021119478A1 (en) 2019-12-11 2021-06-17 Shifamed Holdings, Llc Descending aorta and vena cava blood pumps
CN119901559A (zh) * 2025-01-21 2025-04-29 艾联生物科技(杭州)有限公司 一种用于肠炎模型病理共定位评价的染色试剂盒及染色方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7196054B1 (en) * 1990-11-27 2007-03-27 The American National Red Cross Methods for treating wound tissue and forming a supplemented fibrin matrix
US5782789A (en) * 1994-10-19 1998-07-21 Atrium Medical Corporation Macrochannel phosthetic/delivery patch
CA2222136C (en) * 1995-05-26 2005-04-05 Bsi Corporation Method and implantable article for promoting endothelialization
PT941116E (pt) * 1996-11-01 2005-05-31 Ark Therapeutics Ltd Utilizacao de vegf para o fabrico de um medicamento para o tratamento ou prevencao de hiperplasia da intima e dispositivo de entrega
US5972027A (en) * 1997-09-30 1999-10-26 Scimed Life Systems, Inc Porous stent drug delivery system
GB9809082D0 (en) * 1998-04-28 1998-06-24 Eurogene Limited Delivery device
WO2000030532A1 (en) * 1998-11-20 2000-06-02 University Of Connecticut Generic integrated implantable potentiostat telemetry unit for electrochemical sensors
US6398808B1 (en) * 1999-06-15 2002-06-04 Scimed Life Systems, Inc. Localized delivery of genetic information from biostable materials

Also Published As

Publication number Publication date
CA2392284C (en) 2009-08-18
WO2001041674A1 (en) 2001-06-14
DE60003580T2 (de) 2004-05-27
ES2206342T3 (es) 2004-05-16
US20030059463A1 (en) 2003-03-27
CA2392284A1 (en) 2001-06-14
EP1235536B1 (en) 2003-06-25
CN1239133C (zh) 2006-02-01
JP2003516180A (ja) 2003-05-13
DK1235536T3 (da) 2003-10-20
CN1407873A (zh) 2003-04-02
AU782237B2 (en) 2005-07-14
DE60003580D1 (de) 2003-07-31
AU2242901A (en) 2001-06-18
HK1054858A1 (en) 2003-12-19
SE0000285D0 (sv) 2000-01-31
EP1235536A1 (en) 2002-09-04

Similar Documents

Publication Publication Date Title
ATE243479T1 (de) Medizinische vorrichtung mit nukleinsäurehaltiger synthetischer oberfläche zur in-vivo induktion seiner endothelialisierung
KR101236363B1 (ko) 연조직 증강을 위한 입자
ATE214903T1 (de) Verwendung von perfluorkohlenwasserstoffen zur herstellung von potenzierungsmitteln für die ultraschallvermittelte hyperthermiebehandlung von biologischen geweben
WO2003013239A3 (de) Verfahren zur devitalisierung natürlicher organe und/oder zur bereitstellung extrazellulärer matrices zum 'tissue-engineering'
EP2266501A3 (en) Medical devices comprising nanocomposites
GEP20022804B (en) Erythropoietin Derivatives
WO2002060955A3 (en) Modified antibodies and methods of use
DE69535576D1 (de) Zusammensetzungen von nucleinsäure und viskosität-erhöhendem polymer pvp, zur verwendung in gentherapie
WO2000035371A3 (es) Procedimiento y dispositivo para favorecer el implante de material biologico
DE69333658D1 (de) Verfahren zur behandlung von organen und gewebe
WO2001068811A3 (de) Verfahren zur in vitro-herstellung von dreidimensionalem, vitalem knorpel- oder knochengewebe und dessen verwendung als transplantationsmaterial
WO2004110360A3 (en) Proteoglycan degrading mutants for treatment of cns
WO1999048536A3 (en) Delivery of long lasting therapeutic agents by forming covalent attachments in vivo
AU2001285210A1 (en) Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
ATE172117T1 (de) Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten
WO2003039591A3 (de) Allogene vakzine enthaltend eine ein costimulatorisches polypeptid exprimierende tumorzelle
WO2005010164A3 (en) Nucleic acid biomaterials and methods of formation and use
DE69328527D1 (de) Carboxypeptidase-ähnliches Protein aus Knochen und Verfahren zur dessen Herstellung
ATE267843T1 (de) Verfahren zur herstellung von selbstvernetzten hyaluronsäuren und deren derivaten mittels superkritischer anti-lösungsmittel
DE69331086D1 (de) Protein des Cadherin-Typs aus Knochen und Verfahren zur Herstellung
EP2039348A1 (en) Cosmetic preparation and method to obtain a somatic stem cell preparation
WO2003035126A1 (en) Process for producing biological material, drug, food, medical instrument, cell culture instrument and tissue-inducible material
ATE355083T1 (de) Kit aus polyakrylamidgel zur herstellung einer kapsel im gewebe eines säugetierorganismus und tierischen allogenen oder xenogenen zellen , zur behandlung von onkologischen krankheiten und der diabetes mellitus
SU1392589A1 (ru) Способ моделировани абсцесса
UA40019A (uk) Вентрикулярний резервуар з титановою пластиною

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties